You are here

Targeted, Alternate Serotype Vector for Ovarian Cancer

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43CA109841-01
Agency Tracking Number: CA109841
Amount: $478,188.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Timeline
Solicitation Year: 2004
Award Year: 2004
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
GENVEC, INC. 65 W WATKINS MILL RD
GAITHERSBURG, MD 20878
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 C King
 (240) 632-5537
 RKING@GENVEC.COM
Business Contact
 C KING
Phone: (240) 632-5537
Email: RKING@GENVEC.COM
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): Despite significant improvements in the management of ovarian cancer, approximately 13,900 women per year in the United States are expected to ultimately fail standard therapies and die. For the treatment of ovarian ca

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government